Fundz

Specific Biologics Closes Seed Financing With Industry Leaders Lumira Ventures And Admare Bioinnovations

PRIVATEDec 16, 2021

Round Type

Seed

TorontoInformation TechnologyBiotechnologyHealth CareScience And EngineeringLending And Investments

Description

Specific Biologics Inc. ("Specific") today announced that it has closed its first institutional financing, led by Lumira Ventures and adMare BioInnovations which have recently established an innovative partnership to build Canadian life sciences companies.

Quick answer

Specific Biologics raised an undisclosed amount in a Seed round, dated December 16, 2021. Specific Biologics is based in Toronto, Ontario, Canada.

How much did Specific Biologics raise?
Specific Biologics raised an undisclosed amount in a Seed round on December 16, 2021.
What does Specific Biologics do?
Specific Biologics Inc. ("Specific") is a venture-backed early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through efficient and precise gene editing.
Where is Specific Biologics based and how big is it?
Specific Biologics is based in Toronto, Ontario, Canada. Fundz records about 2 employees.
Who are the decision-makers at Specific Biologics?
Fundz holds 4 contacts at Specific Biologics, including the Associate Director - Pipeline Development. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Science And Engineering and Lending And Investments around the same time

Companies in the same sectors as Specific Biologics that raised within 45 days of this round, from Fundz verified event records.

  • Septerna raised $100M (Series A) on January 27, 2022.
  • Advanced NanoTherapies raised $9.2M on January 26, 2022.
  • Kyverna Therapeutics raised $85M (Series B) on January 26, 2022.
  • Enliven Therapeutics raised an undisclosed amount (Funding Round) on January 19, 2022.
  • Feldan Therapeutics raised an undisclosed amount (Funding Round) on January 18, 2022.
  • PostEra Inc. raised $26M on January 14, 2022.

Who to call at Specific Biologics, and when

A new round usually means Specific Biologics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Specific Biologics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Specific Biologics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Specific Biologics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Specific Biologics

Location

Toronto, Ontario, Canada

About

Specific Biologics Inc. ("Specific") is a venture-backed early-stage biotechnology company on a mission to develop novel gene editing technologies to treat diseases through efficient and precise gene editing. Our differentiated two-site Dualase® platform gene editors cut DNA in a way that optimally exploits the cell's naturally occurring DNA repair pathways. This enables two gene editing outcomes, precise DNA deletions to disrupt genes or increased repair to correct genes to target new therapeutic areas for gene editing. Specific also develops lipid nanoparticles to deliver the gene editor to target cells and is developing a pipeline of Dualase®-based therapeutics in areas of high unmet medical need. To learn more, visit www.specificbiologics.com.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Specific Biologics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsThomas, Associate Director - Pipeline Developme… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Specific Biologics's next move

See what Strategic adds

Specific Biologics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.